Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 20

Venture capital as a service

In last week’s editorial on Louis Dreyfus Corporation’s move to set up an agriculture-focused corporate venturing unit I said: “CVC easy as 123.”

Jun 26, 2020

Healthcare industry shifts herald new phase

GCV Analytics’ webinar, with a discussion panel on the life sciences sector in partnership with Faegre Drinker, showed the power of long-term thinking when it comes to corporate venturing.

Jun 25, 2020

Raising the stakes in climate venture

There is a certain sense of one-upmanship that can be offputting to the rest of the world, but when it comes to tackling climate change and crowding in the trillions of dollars needed from corporations, then the rest of the world can cheer them on.

Jun 24, 2020

Keeping your wits about you in trucking

Daily leader from editor-in-chief James Mawson.

Jun 23, 2020

Life sciences sector comes alive

Daily leader from editor-in-chief James Mawson.

Jun 22, 2020

Slowly, then suddenly, change happens

There are a lot of straws in the wind currently that indicate change could be accelerating in regard to how capital is allocated and to whom.

Jun 18, 2020

Governments need to cure old habits of control

The traditional way to think of supporting entrepreneurs has been to look at their five primary needs: access to capital, finding customers, product and service development, hiring people and, eventually, an exit.

Jun 17, 2020

Europe’s need for a sustainable and equitable investment plan

Europe can respond to the Covid-19 crisis in two ways: restore the past or bounce forward.

Jun 16, 2020

CVC easy as 123

When asked for the Global Corporate Venturing agriculture technology supplement in March, why there is such a boom, Daria Batukhtina, business development manager at Kubota Group, a Japan-based agriculture machinery maker, said: “Business is not as usual.”

Jun 16, 2020

Strategies blur as opportunities arise

Interesting to see Søren Thinggaard Hansen has joined Denmark-based pharmaceutical firm Novo as a senior partner to set up a private equity initiative to complement its existing corporate venturing strategy.

Jun 15, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here